These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16601575)

  • 41. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.
    Jandeleit-Dahm KA; Tikellis C; Reid CM; Johnston CI; Cooper ME
    J Hypertens; 2005 Mar; 23(3):463-73. PubMed ID: 15716683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.
    Estacio RO
    Postgrad Med; 2009 May; 121(3):33-44. PubMed ID: 19491538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [RAAS and insulin resistance].
    Motoshima H; Araki E
    Nihon Rinsho; 2012 Sep; 70(9):1542-9. PubMed ID: 23012801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the renin-angiotensin system and target organ protection.
    Iwanami J; Mogi M; Iwai M; Horiuchi M
    Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
    Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
    Wilkinson-Berka JL
    Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [How to prevent the incidence of hypertension in type 2 diabetes patients].
    Murakami H; Shimamoto K
    Nihon Rinsho; 2003 Jul; 61(7):1154-60. PubMed ID: 12877077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of the renin-angiotensin system in migraine.
    Tronvik E; Stovner LJ; Schrader H; Bovim G
    J Hypertens Suppl; 2006 Mar; 24(1):S139-43. PubMed ID: 16601567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of antihypertensive agents on the development of type 2 diabetes mellitus.
    Stump CS; Hamilton MT; Sowers JR
    Mayo Clin Proc; 2006 Jun; 81(6):796-806. PubMed ID: 16770980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into the biology of diabetic vascular disease: what's new?
    Sowers JR; Stump CS
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):2S-6S; quiz A2-4. PubMed ID: 15539107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma renin and cardiovascular risk: what is the evidence for an association?
    Volpe M; Unger T
    Cardiology; 2013; 125(1):50-9. PubMed ID: 23636010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
    Scheen AJ
    Diabetes Metab; 2004 Dec; 30(6):498-505. PubMed ID: 15671919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.
    Leung PS; de Gasparo M
    J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The renin-angiotensin system in the endocrine pancreas.
    Carlsson PO
    JOP; 2001 Jan; 2(1):26-32. PubMed ID: 11862019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does it matter how blood pressure is lowered in patients with metabolic risk factors?
    Sharma AM
    J Am Soc Hypertens; 2008; 2(4 Suppl):S23-9. PubMed ID: 20409934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and the prevention of diabetes mellitus in obese patients with hypertension.
    Mascitelli L; Pezzetta F
    Hong Kong Med J; 2005 Oct; 11(5):424. PubMed ID: 16219969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.